CSL300_2301_Ph3
Everyone
info
500+
Downloads
Everyone
Learn more
About this app
The CSL Behring CSL300_2301 Phase 3 App is intended for use to collect patient reported outcomes relating to the CSL300_2301 Phase 3 clinical trial. Patients must be given accounts by a participating site in order to log in to the app.
CSL300_2301_Ph3 is intended for collecting patient outcomes for clinical trials.
Updated on
Safety starts with understanding how developers collect and share your data. Data privacy and security practices may vary based on your use, region, and age. The developer provided this information and may update it over time.
- No data shared with third partiesLearn more about how developers declare sharing
- This app may collect these data typesHealth and fitness and App info and performance
- Data is encrypted in transit
- You can request that data be deleted
Everyone
Learn moreApp support
About the developer
eResearchTechnology, Inc.
customercare@clario.com
1818 Market St Ste 2600
Philadelphia, PA 19103-3600
United States
+49 160 4790036
